NCT03881488
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03881488
Title Study of CTX-471 in Patients Post PD-1/PD-L1 Inhibitors in Metastatic or Locally Advanced Malignancies
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Compass Therapeutics
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Ocala Oncology Center Ocala Florida 34474 United States Details
Hematology Oncology Associates Of The Treasure Coast Port Saint Lucie Florida 34952 United States Details
Massachusetts General Hospital Boston Massachusetts 02114 United States Details
Dana-Farber Cancer Institute Boston Massachusetts 02215 United States Details
Washington University School of Medicine, Siteman Cancer Center St Louis Missouri 63110 United States Details
Hackensack University Medical Center Hackensack New Jersey 07601 United States Details
Mt Sinai New York New York 10029 United States Details
Duke University School of Medicine Durham North Carolina 27705 United States Details
Institute for Translational Oncology Research (ITOR) Greenville South Carolina 29605 United States Details
Mary Crowley Cancer Research Dallas Texas 75251 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field